1. Filip I.
   Effect of statins on blood pressure provides added cardioprotective benefit for individuals with HIV.
   AIDS 2026.
   


2. Mendes de Leon KF, Klungers RD, Nieuwkerk PT, Van Der Valk M, et al.
   Willingness to switch to long-acting regimens among people with HIV: a systematic review and meta-analysis.
   AIDS 2026.
   


3. Moussaou ME, Ladang A, Maes N, Cavalie E, et al.
   Heterogeneity of baseline immune activation and SARS-CoV-2 vaccine responses in people with HIV: a multicenter prospective study.
   AIDS 2026.
   


4. Mutenherwa F, Lutalo T, Galiwango RM, Feltes JB, et al.
   Perceived Ethical Risks of HIV Phylogenetic Research: Insights from Professional Stakeholders in Uganda.
   AIDS Res Hum Retroviruses 2026.
   


5. Killander Moller I, Brannstrom J, Elvstam O, Gisslen M, et al.
   Renal Risk and Creatinine Elevation in People With HIV - Broadening the Perspective.
   Clin Infect Dis 2026.
   


6. Manesh A, Aslan AT, Mohan George M, Sulaiman H, et al.
   Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.
   Clin Infect Dis 2026;82:S105-S115.
   


7. Berenguer J, Ryan P, Lutz T, Martin-Carbonero L, et al.
   Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.
   Clin Infect Dis 2026.
   


8. Illescas-Lopez M, Munoz P, de Salazar A, Delgado R, et al.
   HIV-1 APOBEC-context mutations detected by next-generation sequencing in plasma: implications for drug resistance interpretation.
   J Infect Dis 2026.
   


9. Bourgi K, Bian A, Boyd L, Gupta SK, et al.
   Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.
   J Infect Dis 2026.
   


10. Chen Y, Lan Y, Zhao A, Zhang Y, et al.
    Anti-Zika Virus Activity of Azvudine via Inhibition of RNA Replication by Its Active Triphosphate Form.
    J Med Virol 2026;98:e71000.
    


11. Mungale A, Behnia M, Dremel SE, Ziegelbauer JM, et al.
    Vascular Endothelial Growth Factor Receptor 2 (VEGFR2/KDR) Promotes KSHV Lytic Replication and Drives Pro-Inflammatory Cytokine Release and Cancer Signaling.
    J Med Virol 2026;98:e70989.
    


12. Panchapakesan A, Joshi AP, Amanullah A, Pargain N, et al.
    Enhanced strand transfer and mismatch extension by HIV-1C reverse transcriptase promote sequence motif duplication.
    J Virol 2026.
    


13. Kinkade CW, Sheng Q, Peter O, Kumar A, et al.
    Epigenetic Age Acceleration, Neurocognition and Oral Health in Nigerian Adolescents With and Without HIV.
    Pediatr Infect Dis J 2026.
    


14. Cinar EN, Markowich AH, Vergadi E, Lyall H, et al.
    Duration of Postnatal HIV Prophylaxis: How Long Is Long Enough?
    Pediatr Infect Dis J 2026.
    

Display articles in

• Abstract format